AU
UK
CA
NZ
IND
US
3 Key HighlightsSDOT fell 14.42% on 29 May 2026 following a Q1 EPS miss of $127.40 and a 276.7% spike in short interest during May.Short interest reached 154,090 shares as of 15 May, up from just 40,907 shares on 30 April, signalling sharp bearish …
Key HighlightsLBGJ surged 10.18% on 29 May 2026 as traders positioned ahead of imminent 51% Suzhou YufengyuanAcquisitionclosing, adding high-Marginrecurring catering services to stainless-steel kitchen equipmentBusiness.Yufengyuan projected to contribute RMB150 million (~$22 million) to 2026 consolidatedRevenue, material inflection for $3.33 million market cap company pursuing …
Key HighlightsFLYE climbed 11.05% on 29 May 2026 on 6.65x relativeVolumewithout a same-day press release, reflecting concentrated retail buying in a $3.28 million market cap electric motorcycle micro-cap.RecentLeadershiprestructuring in February 2026 (three senior executive departures) andNasdaqcompliance recovery in April 2026 provide backdrop for renewed …
Key HighlightsPAVS rallied 10.48% on 29 May 2026 at $1.16 on extreme 18.81x relativeVolume, demonstrating classic nano-cap flow mechanics where thin float and concentrated positioning amplify price swings independent of fundamental catalysts.The $1.22 millionMarket Capitalisationand heavily shorted position (61.67% short interest) create structural conditions …
Key HighlightsIVF surged 10.59% on 29 May 2026 on extreme 245.72x relativeVolume, one of the most abnormal tape readings on the entire small-cap market, signalling aggressive positioning in post-reverse-split nano-cap.Recent Family Beginnings fertility clinicAcquisition(February 2026) and 1-for-5 reverse split (March 2026) provide operational backdrop …
Absci Corporation (Nasdaq:ABSI) share price climbed 11.02% on 29 May 2026, closing at $6.75 as investors rotated into artificial intelligence-linkedGrowth Stocksduring a record-setting session for US equities. While no major company-specific announcement emerged as the primary catalyst, the stock appeared to benefit from renewed …
Key HighlightsFDMT rose 10.48% on 29 May 2026 to $9.91 on relativeVolumeof 5.96x, driven by gene-therapy sector momentum following Replimune's FDA alignment on resubmission.Trading volume reached 3.32M shares as broader biotech sentiment improved on FDA priority-review signal for oncology gene therapy applications.The move occurred …
Advanced Biomed Inc. (Nasdaq:ADVB) share price surged 28.13% on 29 May 2026, closing at $5.01 and ranking among the top-performing US stocks of the session. The sharp move occurred despite the absence of a widely reported corporate announcement,Earningsupdate, or regulatory filing directly linked to …
Please wait processing your request...